Page 259 - The Netter Collection of Medical Illustrations - Integumentary System_ Volume 4 ( PDFDrive )
P. 259
References Integumentary System
Uzzan B, Konate L, Diop A, et al. Efficacy of four insect repellents Amagai M. Non-pathogenic anti-desmoglein 3 IgG autoantibodies Onodera H, Mihm MC Jr, Yoshida A, et al. Drug-induced linear
against mosquito bites: a double-blind randomized placebo- in Fogo Selvagem. J Invest Dermatol. 2006;126:1931-1932. IgA bullous dermatosis. J Dermatol. 2005;32:759-764.
controlled field study in Senegal. Fundam Clin Pharmacol. 2009; Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus— Ozawa T, Tsuruta D, Jones JC, et al. Dynamic relationship of
23:589-594. an autoimmune mucocutaneous disease associated with neopla- focal contacts and hemidesmosome protein complexes in live
Valencia IC, Falabella A, Kirsner RS, et al. Chronic venous insuf- sia. N Engl J Med. 1990;323:1729-1735. cells. J Invest Dermatol. 2010;130:1624-1635.
ficiency and venous leg ulceration. J Am Acad Dermatol. 2001; Barnadas M, Roe E, Brunet S, et al. Therapy of paraneoplastic Remington J, Chen M, Burnett J, et al. Autoimmunity to type VII
44:401-421. pemphigus with rituximab: a case report and review of literature. collagen: epidermolysis bullosa acquisita. Curr Dir Autoimmun.
Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and J Eur Acad Dermatol Venereol. 2006;20:69-74. 2008;10:195-205.
classification of mastocytosis: a consensus proposal. Leuk Res. Baroni A, Lanza A, Cirillo N, et al. Vesicular and bullous disorders: Sehgal VN, Srivastava G. Paraneoplastic pemphigus/paraneoplastic
2001;25:603-625. pemphigus. Dermatol Clin. 2007;25:597-603. autoimmune multiorgan syndrome. Int J Dermatol. 2009;48:
van der Hilst JC, Bodar EJ, Barron KS. Long-term follow up, Billet SE, Grando SA, Pittelkow MR. Paraneoplastic autoimmune 162-169.
clinical features, and quality of life in a series of 103 patients multiorgan syndrome: review of the literature and support for a Shimizu H. New insights into the immunoultrastructural organiza-
with hyperimmunoglobulinemia D syndrome. Medicine. 2008; cytotoxic role in pathogenesis. Autoimmunity. 2006;39:617-630. tion of cutaneous basement membrane zone molecules. Exp Der-
87:301-310. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. Philadel- matol. 1998;7:303-313.
Vanderhooft SL, Francis JS, Holbrook KA, et al. Familial pityriasis phia: Mosby; 2008:403-446. Shinkuma S, Nishie W, Shibaki A, et al. Cutaneous pemphigus
rubra pilaris. Arch Dermatol. 1995;131:448-453. Bruch-Gerharz D, Hertl M, Ruzicka T. Mucous membrane pem- vulgaris with skin features similar to the classic mucocutaneous
Ventura F, Vilarinho C, da Luz Duarte M, et al. Two cases of phigoid: clinical aspects, immunopathological features and type: a case report and review of the literature. Clin Exp Dermatol.
annular elastolytic granuloma: different response to the treat- therapy. Eur J Dermatol. 2007;17:191-200. 2008;33:724-728.
ment. Dermatol Online J. 2010;16:11. Caldarola G, Annese V, Bossa F, et al. Linear IgA bullous derma- Stirling L, Kirsner RS. Evidence-based pemphigus treatment?
Vergilis-Kalner IJ, Mann DJ, Wasserman J, et al. Pityriasis rubra tosis and ulcerative colitis treated by proctocolectomy. Eur J J Invest Dermatol. 2010;130:1963.
pilaris sensitive to narrow band-ultraviolet B light therapy. J Dermatol. 2009;19:651. Stokes DL. Desmosomes from a structural perspective. Curr Opin
Drugs Dermatol. 2008;8:270-273. Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis Cell Biol. 2007;19:565-571.
Villalón G, Martin JM, Monteagudo C, et al. Eruptive xanthomas and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Templet JT, Welsh JP, Cusack CA. Childhood dermatitis herpeti-
after onset of diabetes mellitus. Actas Dermosifiliogr. 2008; Venereol. 2009;23:633-638. formis: a case report and review of the literature. Cutis. 2007;
99:426-427. Chang JH, McCluskey PJ. Ocular cicatricial pemphigoid: manifes- 80:473-476.
Wada H, Asakura H, Okamoto K, et al. Expert consensus for the tations and management. Curr Allergy Asthma Rep. 2005;5: Woodley DT, Remington J, Chen M. Autoimmunity to type VII
treatment of disseminated intravascular coagulation in Japan. 333-338. collagen: epidermolysis bullosa acquisita. Clin Rev Allergy
Japanese Society of Thrombosis Hemostasis/DIC subcommittee. Chung HJ, Uitto J. Type VII collagen: the anchoring fibril protein Immunol. 2007;33:78-84.
Thromb Res. 2010;125:6-11. at fault in dystrophic epidermolysis bullosa. Dermatol Clin. Zhu X, Zhang B. Paraneoplastic pemphigus. J Dermatol. 2007;34:
Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: 2010;28:93-105. 503-511.
issues in diagnosis and treatment. Am J Clin Dermatol. Culton DA, Qian Y, Li N, et al. Advances in pemphigus and its
2009;10:365-381. endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a Section 6: Infectious Diseases
Walling HW, Swick BL. Pityriasis rubra pilaris responding rapidly paradigm of human autoimmunity. J Autoimmun. 2008;31: Adams BB. New strategies for the diagnosis, treatment, and preven-
to adalimumab. Arch Dermatol. 2009;145:99-101. 311-324. tion of herpes simplex in contact sports. Curr Sports Med Rep.
Walton KE, Bowers EV, Drolet BA, et al. Childhood lichen planus: Daniel E, Thorne JE. Recent advances in mucous membrane pem- 2004;3:277-283.
demographics of a U.S. population. Pediatr Dermatol. 2010;27: phigoid. Curr Opin Ophthalmol. 2008;19:292-297. Adams EN, Parnapy S, Bautista P. Herpes zoster and vaccination:
34-38. Dart J. Cicatricial pemphigoid and dry eye. Semin Ophthalmol. a clinical review. Am J Health Syst Pharm. 2010;67:724-727.
Warren RB, Griffiths CE. The future of biological therapies. Semin 2005;20:95-100. Alfa M. The laboratory diagnosis of Haemophilus ducreyi. Can J
Cutan Med Surg. 2010;29:63-66. Dasher D, Rubenstein D, Diaz LA. Pemphigus foliaceus. Curr Dir Infect Dis Med Microbiol. 2005;16:31-34.
Wedderburn LR, Rider LG. Juvenile dermatomyositis: new devel- Autoimmun. 2008;10:182-194. Anderson AL, Chaney E. Pubic lice (Pthirus pubis): history, biology
opments in pathogenesis, assessment and treatment. Best Pract de Pereda JM, Lillo MP, Sonnenberg A. Structural basis of the and treatment vs. knowledge and beliefs of US college students.
Res Clin Rheumatol. 2009;23:665-678. interaction between integrin alpha6beta4 and plectin at the Int J Environ Res Public Health. 2009;6:592-600.
Weedon D. Skin Pathology. Edinburgh: Churchill Livingstone; hemidesmosomes. EMBO J. 2009;28:1180-1190. Andrews MD, Burns M. Common tinea infections in children. Am
1997. Edgin WA, Pratt TC, Grimwood RE. Pemphigus vulgaris and Fam Physician. 2008;77:1415-1420.
Wetter DA, Camilleri MJ. Clinical, etiologic, and histopathologic paraneoplastic pemphigus. Oral Maxillofac Surg Clin North Am. Ayyadurai S, Sebbane F, Raoult D, et al. Body lice, Yersinia
features of Stevens-Johnson syndrome during an 8-year period 2008;20:577-584. pestis orientalis, and black death. Emerg Infect Dis. 2010;16:
at Mayo Clinic. Mayo Clin Proc. 2010;85:131-138. Egan CA, Zone JJ. Linear IgA bullous dermatosis. Int J Dermatol. 892-893.
Whitton ME, Pinart M, Batchelor J, et al. Interventions for vitiligo. 1999;38:818-827. Bacelieri R, Johnson SM. Cutaneous warts: an evidence-based
Cochrane Database Syst Rev. 2010;CD003263. Eschle-Meniconi ME, Ahmad SR, Foster CS. Mucous membrane approach to therapy. Am Fam Physician. 2005;72:647-652.
Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in pemphigoid: an update. Curr Opin Ophthalmol. 2005;16: Bachmeyer C, Buot G, Binet O, et al. Fixed cutaneous sporotricho-
prevention, diagnosis, and treatment. Semin Dial. 2002;15: 303-307. sis: an unusual diagnosis in West Europe. Clin Exp Dermatol.
172-186. Flores G, Qian Y, Díaz LA. The enigmatic autoimmune response 2006;31:479-481.
Windebank K, Nanduri V. Langerhans cell histiocytosis. Arch Dis in endemic pemphigus foliaceus. Actas Dermosifiliogr. 2009;100 Bansal R, Tutrone WD, Weinberg JM. Viral skin infections in
Child. 2009;94:904-908. (Suppl 2):40-48. the elderly: diagnosis and management. Drugs Aging. 2002;19:
Wolinsky CD, Waldorf H. Chronic venous disease. Med Clin North Hernandez L, Green PH. Extraintestinal manifestations of celiac 503-514.
Am. 2009;93:1333-1346. disease. Curr Gastroenterol Rep. 2006;8:383-389. Baringer JR. Herpes simplex infections of the nervous system.
Wood AJ, Wagner MV, Abbott JJ, et al. Necrobiotic xanthogranu- Hingorani M, Lightman S. Ocular cicatricial pemphigoid. Curr Neurol Clin. 2008;26:657-674.
loma: a review of 17 cases with emphasis on clinical and patho- Opin Allergy Clin Immunol. 2006;6:373-378. Baughn RE, Musher DM. Secondary syphilitic lesions. Clin Micro-
logic correlation. Arch Dermatol. 2009;145:279-284. Humbert P, Pelletier F, Dreno B, et al. Gluten intolerance and skin biol Rev. 2005;18:205-216.
Yang CC, Shih IH, Lin WL, et al. Juvenile pityriasis rubra pilaris: diseases. Eur J Dermatol. 2006;16:4-11. Bechah Y, Capo C, Mege JL, et al. Epidemic typhus. Lancet Infect
report of 28 cases in Taiwan. J Am Acad Dermatol. 2008; James WD, Berger TG, Elston DM. Andrews’ Diseases of the Skin: Dis. 2008;8:417-426.
59:943-948. Clinical Dermatology. Philadelphia: Saunders; 2006:464-465. Benard G. An overview of the immunopathology of human para-
Yang Y, Xu J, Li F, et al. Combination therapy of intravenous Joly P, Roujeau JC, Benichou J, et al. A comparison of oral and coccidioidomycosis. Mycopathologia. 2008;165:209-221.
immunoglobulin and corticosteroid in the treatment of toxic topical corticosteroids in patients with bullous pemphigoid. N Biolcati G, Alabiso A. Creeping eruption of larva migrans—a case
epidermal necrolysis and Stevens-Johnson syndrome: a retro- Eng J Med. 2002;346:321-327. report in a beach volley athlete. Int J Sports Med. 1997;18:
spective comparative study in China. Int J Dermatol. 2009; Kasperkiewicz M, Schmidt E. Current treatment of autoimmune 612-613.
48:1122-1128. blistering diseases. Curr Drug Discov Technol. 2009;6:270-280. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. St. Louis:
Youn SW. The role of facial sebum secretion in acne pathogenesis: Kasperkiewicz M, Zillikens D. The pathophysiology of bullous Mosby; 2008.
facts and controversies. Clin Dermatol. 2010;28:8-11. pemphigoid. Clin Rev Allergy Immunol. 2007;33:67-77. Bonilla DL, Kabeya H, Henn J, et al. Bartonella quintana in body
Zancanaro PC, Isaac AR, Garcia LT, et al. Localized scleroderma Kharfi M, Khaled A, Karaa A, et al. Linear IgA bullous dermatosis: lice and head lice from homeless persons in San Francisco,
in children: clinical, diagnostic and therapeutic aspects. An Bras the more frequent bullous dermatosis of children. Dermatol California, USA. Emerg Infect Dis. 2009;15:912-915.
Dermatol. 2009;84:161-172. Online J. 2010;16:2. Borelli C, Korting HC, Bödeker RH, et al. Safety and efficacy of
Zetterström R. Kostman disease—infantile genetic agranulocytosis: Kitajima Y. Cross-talk between hemidesmosomes and focal con- sertaconazole nitrate cream 2% in the treatment of tinea pedis
historical views and new aspects. Acta Pædiatr. 2002;91: tacts: understanding subepidermal blistering diseases. J Invest interdigitalis: a subgroup analysis. Cutis. 2010;85:107-111.
1279-1281. Dermatol. 2010;130:1493-1496. Bouvresse S, Chosidow O. Scabies in healthcare settings. Curr Opin
Ziemer M, Eisendle K, Zelger B. New concepts on erythema annu- Korman NJ. New and emerging therapies in the treatment of Infect Dis. 2010;23:111-118.
lare centrifugum: a clinical reaction pattern that does not repre- blistering diseases. Dermatol Clin. 2000;18:127-137. Bowman DD, Montgomery SP, Zajac AM, et al. Hookworms of
sent a specific clinicopathological entity. Br J Dermatol. Lehman JS, Camilleri MJ, Gibson LE. Epidermolysis bullosa dogs and cats as agents of cutaneous larva migrans. Trends Para-
2009;160:119-126. acquisita: concise review and practical considerations. Int J Der- sitol. 2010;26:162-167.
Zulian F. New developments in localized scleroderma. Curr Opin matol. 2009;48:227-236. Bradsher RW, Chapman SW, Pappas PG. Blastomycosis. Infect Dis
Rheumatol. 2008;20:601-607. Lessey E, Li N, Dias L, et al. Complement and cutaneous autoim- Clin North Am. 2003;17:21-40.
mune blistering diseases. Immunol Res. 2008;41:223-232. Bratton RL, Whiteside JW, Hovan MJ, et al. Diagnosis and treat-
McDonald HC, York NR, Pandya AG. Drug-induced linear IgA ment of Lyme disease. Mayo Clin Proc. 2008;83:566-571.
Section 5: Autoimmune Blistering Diseases bullous dermatosis demonstrating the isomorphic phenomenon. Brown M, Paulson C, Henry SL. Treatment for anogenital mol-
Al-Amoudi A, Frangakis AS. Structural studies on desmosomes. J Am Acad Dermatol. 2010;62:897-898. luscum contagiosum. Am Fam Physician. 2009;80:864.
Biochem Soc Trans. 2008;36(Pt 2):181-187. McMillan JR, Akiyama M, Shimizu H. Epidermal basement mem- Burgess IF. Current treatments for pediculosis capitis. Curr Opin
Alonso-Llamazares J, Gibson LE, Rogers RS 3rd. Clinical, patho- brane zone components: ultrastructural distribution and molecu- Infect Dis. 2009;22:131-136.
logic, and immunopathologic features of dermatitis herpetifor- lar interactions. J Dermatol Sci. 2003;31:169-177. Carpenter JB, Feldman JS, Leyva WH, et al. Clinical and patho-
mis: review of the Mayo Clinic experience. Int J Dermatol. Mellerio JE. Molecular pathology of the cutaneous basement mem- logic characteristics of disseminated cutaneous coccidioidomyco-
2007;46:910-919. brane zone. Clin Exp Dermatol. 1999;24:25-32. sis. J Am Acad Dermatol. 2010;62:831-837.
THE NETTER COLLECTION OF MEDICAL ILLUSTRATIONS 245

